Funded Tech Companies
Consano Bio
Researching who provided funding to Consano Bio? Private investors put venture money into this biopharmaceutical company.
Company Overview
Company Name
Consano Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
100 Summit Drive
Burlington, MA 01803
USA
Burlington, MA 01803
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Consano Bio is a clinical-stage biotechnology company dedicated to transforming the treatment of painful and debilitating orthopedic conditions through a new class of disease-modifying therapeutics that target the drivers of disease, rather than the symptoms. Consano Bio's lead investigational program, C-1101, is being developed as a potential first-in-class, non-opioid pharmaceutical therapy for chronic painful lumbosacral radiculopathy (LSR), or chronic sciatica. The therapy is designed to deliver a high concentration of proteins from human platelets directly to the site of injury to modulate inflammation and promote localized cell and tissue repair.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/5/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Hall
Chief Marketing Officer
Mark Versavel
Chief Operating Officer
Jennifer Schmitke
VP - Finance
Rahul Bansal
Company Investors
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs